Literature DB >> 263

Monomer complexes of polyadenylic acid.

R Jeremy, H Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 263     DOI： 10.1042/bst0030655

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  45 in total

1.  Antimicrobial resistance of invasive Streptococcus pneumoniae isolates in a British district general hospital: the international connection.

Authors:  Andrew Birtles; Nilangi Virgincar; Carmen L Sheppard; Rachel A Walker; Alan P Johnson; Marina Warner; Valerie Edwards-Jones; Robert C George
Journal:  J Med Microbiol       Date:  2004-12       Impact factor: 2.472

2.  Bacterial meningitis--a view of the past 90 years.

Authors:  Morton N Swartz
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

3.  Activity of mecillinam against ESBL producers in vitro.

Authors:  K Thomas; M J Weinbren; M Warner; N Woodford; D Livermore
Journal:  J Antimicrob Chemother       Date:  2005-12-14       Impact factor: 5.790

Review 4.  Safety of newer parenteral antibiotics.

Authors:  Gary E Stein
Journal:  Clin Infect Dis       Date:  2005-09-01       Impact factor: 9.079

Review 5.  Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

Authors:  Curtis G Gemmell; David I Edwards; Adam P Fraise; F Kate Gould; Geoff L Ridgway; Rod E Warren
Journal:  J Antimicrob Chemother       Date:  2006-02-28       Impact factor: 5.790

6.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

7.  Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Authors:  Vance G Fowler; Helen W Boucher; G Ralph Corey; Elias Abrutyn; Adolf W Karchmer; Mark E Rupp; Donald P Levine; Henry F Chambers; Francis P Tally; Gloria A Vigliani; Christopher H Cabell; Arthur Stanley Link; Ignace DeMeyer; Scott G Filler; Marcus Zervos; Paul Cook; Jeffrey Parsonnet; Jack M Bernstein; Connie Savor Price; Graeme N Forrest; Gerd Fätkenheuer; Marcelo Gareca; Susan J Rehm; Hans Reinhardt Brodt; Alan Tice; Sara E Cosgrove
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

8.  Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.

Authors:  Dennis L Stevens; Daniel Herr; Harry Lampiris; John Lee Hunt; Donald H Batts; Barry Hafkin
Journal:  Clin Infect Dis       Date:  2002-05-13       Impact factor: 9.079

9.  Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Authors:  John Weigelt; Kamal Itani; Dennis Stevens; William Lau; Matthew Dryden; Charles Knirsch
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

10.  Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

Authors:  Richard G Wunderink; Jordi Rello; Sue K Cammarata; Rodney V Croos-Dabrera; Marin H Kollef
Journal:  Chest       Date:  2003-11       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.